Abstract
The prevalence of seven different mutations (84GG, IVS2+1, 754A, 1226G, 1342C, 1448C, and 1504T) was investigated in 32 unrelated Japanese Gaucher patients of which 20 were type I, 6 were type II, and 6 were (type III). These mutations constitute 95% of the mutations observed in Jewish patients with Gaucher disease and 75% of the mutations in non-Jews (European). The most frequent mutation, 1448C (L444P), accounted for 26 alleles (40.6%); the second most prevalent mutation was 754A (F213I), accounting for 7 alleles (10.9%); 27 alleles (42.2%) were unidentified. To data, neither the 1226G (N370S) nor 84GG mutations have been identified in the Japanese population though these alleles account for approximately 70% and 10% of mutations in the Jewish population. These data suggest that mutant alleles identified from the Japanese population are distinct from those observed in Jewish and non-Jewish (European) patients with Gaucher disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amaral O, Lacedra L, Santos R, Pinto R, Aerts H, Sa Miranda MC (1993) Type I Gaucher disease: molecular, biochemical and characterization of the patients from Northern Portugal. Biochem Med Metab Biol 49:97–107
Barranger JA, Ginns EI (1989) Glucosylceramide lipidoses: Gaucher disease. In: Scriver CR, et al (eds) The metabolic basis of inherited disease McGraw-Hill, New York, pp 1677–1698
Beutler E (1992) Gaucher disease: new molecular approaches to diagnosis and treatment. Science 256:794–799
Beutler E, Gelbart T (1993) Gaucher disease mutations in non-Jewish patients. Br J Haematol 85:401–405
Beutler E, Gelbart T, Kuhl W, Sorge J, West C (1991) Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci USA 88: 10544–10547
Beutler E, Gelbart T, Kuhl W, Zimran A, West C (1992) Mutations in Jewish patients with Gaucher disease. Blood 79:1662–1666
Beutler E, Nguyen NJ, Henneberger MW, Smolec JM, McPherson RA, West C, Gelbart T (1993) Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet 52:85–88
Dahl N, Langerstrom M, Erikson A, Pettersson U (1990) Gaucher disease type III (Norrbottnian type) is caused by single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet 47:275–278
Glenn D, Gelbart T, Beutler E (1994) Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) gene. Hum Genet 93:635–638
He GS, Grabowski GA (1992a) Gaucher disease: a G+1 to A+1 IVS splice donor site mutation causing exon skipping in the acid beta-glucosidase mRNA. Am J Hum Genet 51:810–820
He GS, Grace ME, Grabowski GA (1992b) Gaucher disease: four rare alleles encoding F213I, P289L, T323I and R463C in type I variants. Hum Mutat 1:423–427
Hong CM, Ohashi T, Yu XJ, Weiler S, Barranger JA (1990) Sequence of two alleles responsible for Gaucher disease. DNA Cell Biol 9:233–241
Horowitz M, Tzuri G, Eyal N, Berebi A, Kolodny EH, Brady RO, Barton NW, et al (1993) Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients. Am J Hum Genet 53:921–930
Kawame H, Eto Y (1991) A new glucocerebrosidase-gene missense mutation responsible for neuropathic Gaucher disease in Japanese patients. Am J Hum Genet 49:1378–1380
Lewis BD, Nelson PV; Robertson EF, Morris CP (1994) Mutation analysis of 28 Gaucher disease patients: the Australasian experience. Am J Med Genet 49:218–223
Masuno M, Tomatsu S, Sukegawa K, Orii T (1990) Non-existence of a tight association between a 444leucine to proline mutation and phenotypes of Gaucher disease: high frequency of a NciI polymorphism in the non-neuropathic form. Hum Genet 84:203–206
Saiki R (1990) Amplification of genomic DNA. In: Innis MA, Gelfand D, Sninsky JJ, White TJ (eds) PCR protocols: a guide to methods and applications. Academic Press, San Diego
Sibille A, Eng CM, Kim SJ, Pastores G, Grabowski GA (1993) Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. Am J Hum Genet 52:1094–1101
Theophilus BDM, Latham T, Grabowksi GA, Smith FI (1989) Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid beta-glucosidase gene. Nucleic Acids Res 17:7707–7722
Tsuji S, Choudary DV, Martin BM, Stubblefield BK, Mayor JA, Barranger JA, Ginns EI (1987) A mutation in the human glucocerebrosidase gene in neuropathic Gaucher's disease. N Engl J Med 316:570–575
Tsuji S, Martin BM, Barranger JA, Stubblefield BK, La Marca ME, Ginns EI (1988) Genetic heterogeneity in type I Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc Natl Acad Sci USA 85:2349–2352
Wang T, Okano Y, Eisensmith RC, Harvey ML, Lo WHY, Huang SZ, Zeng YT, et al. (1991) Founder effect of a prevalent phenylketonuria mutation in the Oriental population. Proc Natl Acad Sci USA 88:2146–2150
Zevin S, Abrahamov A, Hadas-Halpern I, Kannai R, Levy-Lahad E, Horowitz M, Zimran A (1993) Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy. Q J Med 86:565–573
Zimran A, Gelbart T, Beutler E (1990) Linkage of the PvuII polymorphism with the common Jewish mutation for Gaucher disease. Am J Hum Genet 46:902–905
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ida, H., Iwasawa, K., Kawame, H. et al. Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations. Hum Genet 95, 717–720 (1995). https://doi.org/10.1007/BF00209497
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00209497